WHO-GMP contract manufacturer of generic pellets and oral dosage forms for emerging markets
Pelltech Healthcare manufactures generic solid oral dosage forms (pellets, tablets, capsules) under PICS and WHO-GMP certification for emerging-market pharma. The tech stack—HPLC, UPLC, Chromeleon, SAP—reflects a compliance-heavy, analytical-first operation. Hiring skews 5:1 toward manufacturing and quality roles, with active projects centered on method validation, equipment commissioning, and regulatory readiness, signaling a company in active capacity buildout or facility audit preparation.
Pelltech Healthcare is a privately held contract manufacturer headquartered in Mumbai, India, founded in 2004. They specialize in generic formulations and bioequivalent products, producing conventional and modified-release pellets in capsule and tablet form for pharmaceutical distributors and OEMs across emerging markets. Operations are governed by PICS and WHO-GMP certification. The business model combines in-house analytical capability (HPLC, UPLC) with SAP-based manufacturing execution and quality management.
Pelltech manufactures generic solid oral dosage forms—pellets, tablets, and capsules—primarily for emerging markets. Products include conventional and modified-release formulations under WHO-GMP and PICS certification.
HPLC and UPLC for analytical testing; Chromeleon for chromatography data management; SAP and SAP Business One for manufacturing execution and enterprise resource planning; standard office tools (Excel, Word, PowerPoint) for documentation.
Other companies in the same industry, closest in size